Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer
Clinical trial NCT03276156 · UNKNOWN
Trial details
- NCT number
- NCT03276156
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-23
- Primary completion
- 2018-02-22
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.